This inventor holds 1 USPTO granted patent. Top assignee: Beone Medicines | Gmbh. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: GAng Lv: Inventor in Targeted Protein Degradation
Introduction
GAng Lv is an inventor based in Beijing, China. His patent work concerns targeted protein degradation, an approach that uses cellular machinery to break down selected proteins.
Latest Patents
Lv is associated with 1 patent: “Degradation of Bruton's Tyrosine Kinase (BTK) by Conjugation of BTK Inhibitors with E3 Ligase Ligand and Methods of Use.” The patent describes bifunctional compounds that join BTK inhibitor components with E3 ligase ligand components. These compounds are designed to recruit BTK to an E3 ubiquitin ligase for degradation, and the disclosure also covers methods of preparation and use.
Career Highlights
The supplied information identifies Lv as working with BeOne Medicines GmbH. His listed patent reflects work on compounds intended to direct a disease-associated protein toward degradation.
Collaborations
Lv’s listed coworkers include Changxin Huo and Hexiang Wang. Their names are associated with the same patent information provided.
Conclusion
GAng Lv’s documented invention focuses on using E3 ligase recruitment to promote BTK degradation, contributing to research into targeted protein-degradation methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile